tirzepatide and vision issues GLP-1 Medications Your Vision: What You Should Know Is Terzepatide Causing Blindness |

(3) Its easy to understand why many people see growth hormone therapy as the fountain of youth

Peak pain occurred at 72 hours post-injection

Wegovy, a higher-dose formulation of the same active ingredient, received FDA approval in 2021 explicitly for chronic weight management in adults with obesity or overweight with at least one weight-related health condition

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores

This would mean more lawsuits filed against Novo Nordisk for Ozempic-related injuries